Searched for
THERAPIES FOR BLINDNESS
The Nobel-winning breakthrough that turned light into a remote control for the brain, allowing scientists to switch neurons on and offOptogenetics, a groundbreaking technique, enables researchers to control specific neurons using light, providing insights into brain functi...- Eyestem presents interim Phase 2 data for Eyecyte-RPE™ at EURetina 2026 ConferenceEyestem Research has presented interim results from its Phase 2 clinical trial of Eyecyte-RPE™. The trial focuses on Geographic Atrophy sec...
- 150-year-old human might already be among us, claims Harvard scientist. His experiment may have unlocked how long we can really liveWhat if humans could eventually live for 150 years, not through a simple extension of existing treatments but by actually turning back some...
- Netflix October 2026 Arrivals: Here's the complete list of new titlesIn October 2026, numerous new titles of movies, shows and documentaries will arrive at Netflix throughout the month. Here is the complete l...
- Scientists injected cells from woman’s leg into her eyes to help restore her vision: How 'world-first experiment' went & what doctors discoveredScientists injected mitochondria taken from a woman’s leg into both of her eyes in an experimental attempt to boost energy production in da...
- Don't miss the cannabis busCountries worldwide are lifting cannabis restrictions, leading to a global market resurgence. North America is spearheading this movement w...
- In 2025, Trump administration made shocking decisions for CDC but U.S. Federal Health Agency has new headache of 'zombie programs'. All you may want to knowIn January, Congress passed an appropriations bill, which became law, that specified funding for more than 200 projects and activities.
- Arantxa Sánchez Vicario opens up about her trauma: How the former US Open champion and four-time Grand Slam winner lost £31 million after trusting ex-husband with her financesFormer tennis champion Arantxa Sánchez Vicario, who has won US Open, French Open and Grand Slam titles four times, lost millions after trus...
- Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyte-RPEEyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell therapy. This treatment ...
- Just one dose of 'magic mushroom' compound was given to cancer patients, the long-term results shocked researchersA recent study published in Cancer reveals that a single dose of psilocybin, combined with therapy, offers long-lasting relief from depress...
- Going for broke(r)A stockbroker seeks therapy for market-induced anxiety, revealing his emotions always contradict market movements. Through playful “exposur...
- Affordable gene and cell therapies need of the hour: Dr Kapil Bharti, Scientific Director, National Eye InstituteLimitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.
- US halt to plasma therapy brings a severe jolt to treatment plans in IndiaThe study on plasma therapy by the ICMR is still ongoing, and the results will be shared on completion of the study. The ambiguity, experts...
- Do you experience flashes of light, distortion of images, cloudy vision? Screening for retinal diseases early can be beneficialIt is important for everyone to detect drop in vision at the earliest stage.
- Blue light from digital devices could accelerate blindnessWashington, Aug 13 (IANS) Blue light from digital devices including smartphones could accelerate blindness, researchers have found.
- Novartis's $475,000 cancer breakthrough heralds new era of curesThe U.S. Food and Drug Administration on Wednesday approved a radical new one-time treatment from the Swiss drugmaker, weeks earlier than e...
- How a Bengaluru lab is trying to fix the gene as therapy for hereditary health problemsAs Narayana Nethralaya is fronting it, the focus is on ocular (eye) diseases, though Ghosh’s own area of work is in muscular dystrophy.
- Stem cell therapy may mend damaged hearts, says researchEnd-stage heart failure patients treated with stem cells harvested from their own bone marrow experienced 37 per cent fewer cardiac events.
- Sun Pharma gains on JV to develop new drugsThe joint venture will leverage Sun Pharma’s global capabilities and experience in developing and manufacturing complex dosage forms and sp...
- Sun Pharma inks JV with US-based Intrexon Corp to develop gene therapiesThe 50:50 deal will leverage Sun Pharma’s global capabilities and experience in developing complex dosage forms and specialty pharmaceutica...
Load More
